Medical Science Liaison (MSL) Hematology

Alpha Clinical Development; Poland (ME); Hybrid; USD 90,000 - 130,000; Full time

Job summary

Alpha Clinical Development seeks an experienced Medical Science Liaison (MSL) to support ongoing Phase III clinical trials in hematologic malignancies, focusing on Acute Promyelocytic Leukemia (APML). The MSL will act as a bridge between the organization and key medical experts, providing scientific support, engaging with stakeholders, and disseminating clinical insights. With 5-8 years of relevant experience and an advanced degree required, this role involves travel and collaboration across various teams.

Qualifications

• 5 - 8 years of industry experience, including direct MSL or field-based Medical Affairs roles.
• Demonstrated experience supporting Phase III clinical trials.
• Strong background in hematologic malignancies or rare hematology; APML experience preferred.

Responsibilities

• Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals.
• Engage with KOLs to discuss clinical data and study progress.
• Provide medical and scientific support for ongoing Phase III clinical trials.
• Support clinical trial sites with protocol education and disease awareness.

Skills

Strong communication skills

Stakeholder engagement

Analytical skills

Education

Advanced degree (MD, PharmD, or PhD)

Job description

Position Summary

Our client is seeking an experienced Medical Science Liaison (MSL) to serve as a key scientific resource in the field, with a focus on supporting ongoing Phase III clinical trials. The MSL will act as a bridge between the organization and external medical experts, including Key Opinion Leaders (KOLs), investigators, and healthcare professionals. This role will focus on hematologic malignancies, particularly Acute Promyelocytic Leukemia (APML), and will play a critical role in scientific exchange, stakeholder engagement, and dissemination of clinical insights. This role involves approximately 40% of travel. The contract is open-ended for the duration of the project, with full engagement expected across the entire project timeline.

Key Responsibilities

• Serve as a scientific liaison between the organization and KOLs, investigators, and healthcare professionals (HCPs)
• Engage with KOLs and study investigators to discuss clinical data, study progress, and scientific updates
• Provide medical and scientific support for ongoing Phase III clinical trials
• Support clinical trial sites with protocol education, disease awareness, and non-promotional scientific guidance
• Respond to complex scientific and medical inquiries related to APML and investigational therapies
• Collect and communicate field insights, clinical feedback, and unmet medical needs to internal stakeholders
• Facilitate scientific exchange initiatives and enhance study awareness within the assigned region
• Collaborate cross-functionally with clinical, regulatory, and medical affairs teams to ensure aligned communication
• Support site identification, investigator engagement, and Investigator-Sponsored Trials (ISTs)
• Maintain awareness of pharmacovigilance processes and support safety reporting activities as required

Qualifications & Profile

• Advanced degree (MD, PharmD, or PhD) in a relevant scientific or medical discipline
• 5 - 8 years of industry experience, including direct MSL or field-based Medical Affairs roles
• Demonstrated experience supporting Phase III clinical trials
• Strong background in hematologic malignancies or rare hematology; APML experience preferred
• In-depth understanding of clinical research, ICH-GCP, and regulatory environment
• Strong communication, stakeholder engagement, and analytical skills
• Ability to work independently and collaboratively in a cross-functional environment